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Abstract
Background: Although many studies have investigated the relationship between the introduction of the New
Cooperative Medical Scheme (NCMS) in rural China in 2003 and increased use of medical services, the effect on
health status, objectively measured, is seldom reported. In Anhui Province a chronic disease scheme (CDS) for
reimbursing part of the cost of outpatient care is designed to improve management of those with chronic
conditions, including diabetes.
Methods: A follow-up study was designed in which patients with diabetes aged 40–70 years who had recently
(in 2010) been granted a chronic disease card were individually matched on age, sex and village with a patient
with diabetes not yet in the scheme. Each subject gave a fingertip sample of blood to give the concentration of
glycosylated hemoglobin (HbA1c), a measure indicating blood glucose control during the previous 3 months. This
measure was made on recruitment and at 12 month follow-up: information on use of health services, quality of life
and financial burden was also collected at the two contacts.
Results: Of 602 pairs initially recruited, 528 pairs were contacted at follow-up and are the subject of this report. To
distinguish between outcomes associated with application and those of membership of the scheme, the primary
analysis was of 256 pairs in which one had been a member of the CDS throughout and the other never applied.
No difference between pairs on HbA1c was found either at recruitment or follow-up but those in the CDS reported
more hospital visits, more tests and more use of high level hospitals. However they had poorer scores on quality of
life scales (SF-12, EQ-5D) and were more likely to report that the financial costs were very burdensome. Those
recently applying for the scheme, or being accepted since recruitment, had lower HbA1c scores.
Conclusions: On-going membership of the CDS was associated with increased use of services but this did not
appear to result in better management of blood glucose or improved quality of life. Those who had recently joined
the scheme had signs of improvement, suggesting a need for active follow-up to maintain and reinforce early
gains.
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Background
The new cooperative medical scheme (NCMS) for rural
China was launched in 2003 to protect against impover-
ishment arising from catastrophic health expenditures
and to improve the health status of rural residents. By
2012 almost all rural residents chose to join the scheme
[1]. There have been a number of studies of the impact
of the scheme on access to care, on patterns of care (in-
cluding medications) and on the effectiveness in redu-
cing the financial burden of catastrophic illness [2–5].
The impact on the health of participants has been much
less well documented, in part because of difficulties in
measuring effects of health care objectively. A recent
systematic review found 12 studies of the relationship
between NCMS membership and health outcome: all
used reports of sickness or injury in the last 2–4 weeks
or self-reports of health status. Conclusions were incon-
sistent, with no clear evidence that the NCMS improves
health outcomes [6]. A clinical outcome, the control of
hypertension, was used in one study to assess the effect-
iveness of the NCMS but concluded that NCMS mem-
bership contributed little [7]. There have been no studies
using the success in controlling diabetes as a measure of
the effectiveness of the NCMS: an earlier report consid-
ered the relation between reimbursement schemes and
use of health services using diabetes as a ‘tracer’ condi-
tion but did not assess health outcome. [8] Diabetes,
however, is particularly well suited for the assessment of
clinical impact. It is common, has serious outcomes and
has a biological marker that reflects the success of inter-
ventions. HbA1c measured from a blood sample, reflects
the closeness of control of blood glucose in the preced-
ing months. This provides an opportunity to evaluate
the effect of health insurance during a relatively short
period of follow-up. The present report considers the
impact on diabetic control of a chronic disease program
put in place in Anhui province as one part of that prov-
ince’s NCMS.
The national model for the NCMS has common
features across the country, including compensation for
hospital inpatient stays and of outpatient costs for those
with chronic disease. Each province has freedom to
institute its own programs within these general guide-
lines. In Anhui province a chronic disease scheme (CDS)
was added to the basic provisions of the NCMS. The
study reported here was begun in 2010 and assessed the
impact of membership of the CDS on patients diagnosed
with diabetes. The scheme in place at that time paid
40 % of the costs of outpatient care and medications, to
a maximum of 2000–3000 yuan/year (depending on
county). There was, at the time, no clear clinical guide-
line as to treatment or frequency of follow-up.
In order to be accepted for the CDS a patient with
diabetes had to be a member of the NCMS (a rural
resident of Anhui not eligible for other health insurance
schemes) whose diagnosis of diabetes had been con-
firmed by a specialist physician and who had been
prescribed medication for this condition. The study
reported here aimed to determine whether, having
allowed for any important between group differences,
those in the CDS had better control of their diabetes,
more extensive diabetes related care, or better quality of
life than those who had not yet joined the scheme.
Methods
The study setting
Anhui is an in-land province in Eastern China; Hefei,
the capital, lies 550 miles south of Beijing. Until recently
Anhui has been one of China’s poorer areas. Although
Hefei is now booming, there are still many poor counties
with rural inhabitants very largely working in agriculture
and with low household incomes. The north of the prov-
ince is flat and densely populated, with the south and
west more mountainous and with difficult access. In
2010, when this study was begun, the overall population
was close to 60 million. The province had 105 county-
level divisions covered by 108 NCMS offices.
Study design
This was a longitudinal (follow-up) study of two cohorts
of patients diagnosed with diabetes living in six counties
of Anhui. Within each county, patients with diabetes aged
40–70 years with chronic disease cards (‘cases’) were indi-
vidually matched with patients diagnosed with diabetes
without cards (‘referents’), on age, sex and village. Infor-
mation was collected at baseline (close to the date at
which the card of the case was issued) and after
12 months. Cross-over was allowed: someone not in the
scheme could join, or someone in the scheme could leave
without being excluded from the study. The study was
designed to be analysed using a case-referent approach.
Choice of study areas
In order to identify counties eligible for inclusion, the
provincial health bureau approached 87 NCMS offices
asking for numbers of patients in the chronic disease
scheme and the proportion of patients for which age
was recorded: 67 responded. Of these, 17 had age data
for at least 90 % of patients for whom a chronic disease
card had been approved. Counties were then eliminated
if road access was very difficult or if, from past experi-
ence, collaboration was very unlikely. Six counties were
chosen from the remaining pool, two with high rates of
issuing cards, two with moderate rates and two with
low. As no county from the north of the province was
chosen by this approach, one county with age present
for >80 % of those in the CDS and a moderate rate of
issuing cards was substituted.
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For the six counties identified in this way, further in-
formation was sought on the number of chronic disease
registrations for diabetes and the date at which the
scheme for diabetes was implemented. Resources
allowed recruitment of 600 cases (card registrations)
overall, and a target for each county was set, reflecting
the number of new registrations/month. Information on
the six counties and their participation in the CDS
scheme is given in Table 1. To obtain a CDS card, the
patient was assessed by a diabetic specialist and paid
out-of-pocket for this at, depending on county, a
county-level or township hospital, but not at a village
clinic. In some counties applications for a CDS card
could be made only once a year, in others at any time,
with similar variations in frequency of reimbursement.
The year in which the CDS scheme was first imple-
mented ranged from 2006–2009, but no county had
completely identified all patients with diabetes
potentially eligible for the scheme by the time of the
study.
Identification of patients with and without a chronic
disease registration
In each of the 6 counties the NCMS staff listed all
patients with diabetes in the CDS. The name, age, sex
and phone number of those first receiving a card in
2010 were extracted, together with, in 4 counties, the
most recent registrations from 2009. It was necessary to
involve the township health centre (THC) for each
village containing a case: for efficiency all potential cases
(patients with CDS cards) within a single village were
identified and the village clinic doctor acting as adminis-
trator (VCDA) was contacted by the THC. The VCDA
then provided the ages, where missing, of potential
cases. Because of serious logistic difficulties in carrying
out the fieldwork, townships close to the county town
were approached first, with more distant areas being
included only if the target number of cases for the
county could not be met in the more proximal villages.
There was no central register of patients with diabetes
not registered for the CDS. In each village with an eli-
gible case the VCDA listed all patients with diabetes
aged 40–70 years known to the clinic. Those with a CDS
card were then identified by the team from the lists
supplied by the NCMS office and the remaining, poten-
tial referents, matched within village by age and sex to
the identified cases. Where more than one referent (a
patient with diabetes not in the CDS) was available, the
one closest in age was approached first.
Recruitment
Where possible patients both with and without a CDS
card met with the research team at the village clinic and
recruitment procedures and baseline data collection car-
ried out there. Where a potential subject did not want to
go to the clinic, the clinic VCDA went with the research
team to the subject’s home. As the team could only be
in the village for, at most, a few days, if a case could not
be contacted in that time he or she was dropped from
the study and replaced by another patient with a CDS
card. If a referent could not be contacted and a second
matched referent was available, this one was used. Only
pairs (case and referent) were retained for the study.
Following an explanation of the project by the research
staff the subject was asked to read an information sheet
and sign consent. For illiterate subjects the information
sheet and consent form were read to them and consent
signified by a thumb print.
Contacting subjects at follow-up
Patients who had agreed to be in the study were con-
tacted again, 12 months after recruitment. The meeting
between the research team and the patients was again
arranged through the THC and the VCDA, with data
collection at the village clinic or in the home. Multiple
visits were made to the villages as necessary to obtain a
high response at follow-up.
Data collected
Information was collected by face-to-face interviews,
using a questionnaire developed for this study. This
included questions on date of diagnosis, use of health
care facilities, medication, diabetic care given in the last
12 months and perceived impact of diabetes. Subjects



















A 221,955 2006 360 Mod Anytime County 2× year 2500
B 592,122 2006 522 Low 1× year Township Anytime 2000
C 319,328 2007 610 Mod Anytime County 1× year 3000
D 238,096 2009 514 High 4× year Township Anytime 2500
E 1,289,211 2008 800 Low 1× year Township 2× year 2000
F 772,116 2009 2008 High 1× year Township 1× year 2500
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were also asked about diet, smoking, alcohol use, em-
ployment and education. They completed two quality of
life scales (the SF-12 and EQ-5D), for which there were
established Chinese (Mandarin) versions [9, 10]: these
were administered aurally for illiterate subjects. Partici-
pants were weighed and their height measured for the
calculation of BMI. Capillary (fingertip) blood taken to
measure HbA1c (using a DCA vantage analyzer), an in-
dicator of blood glucose over the preceding weeks.
The questionnaire and tests were repeated at the
12 month follow-up interview, omitting items (educa-
tion, height) unlikely to have changed.
Outcome measures
1) Control of diabetes was measured by the value of
HbA1c at baseline and follow-up: this measure
reflects blood glucose concentration over the
previous 3 months, with a higher level indicating
worse control of diabetes.
2) Quality of diabetes-related care was reflected in:
i). whether the patient had been seen for diabetes at
a higher level (county) hospital or only at the
local township hospital;
ii). the number of recommended checks (0–4)
reported by the patient. These were
examinations, carried out in the last 12 months
as part of their health care, of blood glucose (to
assess diabetic control), urine (to look for renal
damage), eyes (to look for diabetic retinopathy)
and feet (to look for skin lesions);
iii). the total number of hospital visits for diabetes
made in the previous 12 months: in Anhui
province at this time village clinic doctors could
not prescribe diabetic medication so all diabetic
care entailed hospital visits.
3) Quality of life was measured by
i) the physical and mental component summary
scores of the SF-12 [9]. Scores were normalized
to a mean of 50 and range 0–100: high scores
indicated better health;
ii) the health score from the visual analogue scale of
the EQ-5D on a scale 0–100 with high scores
indicating better health [10].
4) Economic burden was reflected in a self-report that
the cost of treatment for diabetes was greatly or very
greatly a burden to themselves and their families.
Statistical methods
A substantial numbers of those registered as having been
approved for a CDS card reported at baseline that they
had not yet been notified of the decision. Because of
this, the main analysis was restricted to matched pairs in
which one patient (the case) reported having received
their CDS card at baseline and the other (the referent)
reported never having applied for a card by the time of
the follow-up interview. Within this subset of the popu-
lation, the design was multi-level with repeat measures
on the same subject, with cases matched to referents
and both cases and referents clustered within county. In
this analysis we used a multi-level logistic model
(GLLAMM within STATA) to examine the benefit (or
risk) associated with being a member of the chronic
disease scheme. We first considered whether those not
applying for the scheme had a more adverse change
between baseline and follow-up in markers of health and
wellbeing than those in the scheme throughout. In a
secondary analysis, we considered whether those who
joined the scheme between baseline and follow-up were
at less at risk (did better) than those who applied but
had not (yet) been approved. Again a multi-level logistic
model was used, allowing for clustering within county
but without taking account of the original matched
design.
Results
A total of 2052 cases recorded as being in the CDS were
extracted. Of these, 514 were not approached because
the target had already been reached, 434 were not used
because no referent could be identified and 182 were
not at home when the team visited. A further 253 had
moved away to live or work, or were staying with rela-
tives in another village, 36 were in villages where the
village doctor refused, 21 had died, nine were the wrong
age and three refused: 602 were recruited for the study.
Of 1440 referents identified but not used, 851 were not
needed because a closer match was found, 272 already
had a CDS card, 201 were the wrong age, 93 were not at
home when the team visited, 21 denied having diabetes
and two refused: 602 patients with diabetes but without
a card were recruited.
Of the 602 pairs recruited at baseline all but 78
subjects (36 cases, 42 referents) were successfully
interviewed at follow-up, on average 368 days (range:
300–590 days) after the first interview. There was no
significant difference between cases and referents in the
reason for no contact (p = 0.50). Twenty (10 cases, 10
referents) had died, 32 were working away, 11 had
moved away, for seven the house was locked and empty,
five refused, two were visiting relatives, and one was in
hospital. To facilitate comparison of changes between
baseline and follow-up, only the 528 pairs in which both
case and referent were contacted twice were included in
the analyses reported here.
Although all the cases and none of the referents were
recorded in NCMS records as having been issued with
chronic disease cards, this did not necessarily coincide
with the reports of the subjects, with many cases saying
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that the result of their application was still pending.
Moreover, many of the referents had already started the
process of applying. The distribution of cases and refer-
ents by self-reports of applying for and receiving the
card is shown in Table 2. Only nine cases reported never
applying for the card although a further 35 said that they
had not applied (or did not know if they had applied) at
baseline. Similarly only six referents reported at baseline
they had received the card although 48 said that they
had applied.
Initial inspection of the data suggested that the values
of the outcome measures at the time of the baseline
questionnaire were related to the recency of the CDS
application (Table 3). Those who had applied in the
12 months before the baseline interview reported under-
going more types of monitoring tests, more hospital
visits and greater proportions visiting a high level
hospital in the last 12 months than those either not
applying or applying more than 12 months previously:
their HbA1c, at 7.69, was lower (better) than that of ei-
ther those who had not applied (8.03) or those who had
applied earlier (8.10) and this difference was unlikely to
have arisen by chance (p = 0.03). Those not applying for
the CDS by baseline had somewhat better quality of life
as reflected in the physical and, particularly, the mental
health component score of the SF-12, and were very
much less likely to report that they were greatly
burdened by the cost of treatment.
The subsequent analysis compared only those who
had joined the scheme before baseline with those who
had never applied. Using a matched analysis as originally
planned, it first considers 258 matched pairs (76 male
and 182 female) in which both NCMS records and self-
report confirmed that the case had received the card by
baseline and in which the referent reported that they
had not applied for a chronic disease card for diabetes
by the time of the 12 month follow-up. This sub-
population allows us to estimate the ongoing impact of
application and membership through changes in
outcome measures between baseline and follow-up.
The baseline characteristics of these 258 pairs (Table 4)
demonstrate that they had been well matched on age.
There were differences between cases and referents in
the time since diagnosis, with both men and (particu-
larly) women in the scheme reporting that their diagno-
sis had been at a more distant date than those who had
not applied for the scheme. Cases were also much more
likely to be using insulin at baseline (65 cases but only 9
referents): the large majority of both cases and referents
not using insulin reported using Western oral diabetic
treatments with only 6.6 % of cases and 20.5 % of refer-
ents using no medication or only traditional Chinese
Table 2 Self-reported timing of application for, and reception of, a chronic disease card (N = 1056)
NCMS reports card NCMS reports no card
Card received Card received
Application for card Never Before baseline After baseline Total Never Before baseline After baseline Total
Never 9 0 0 9 383 0 0 383
After baseline 3 0 32 35 43 0 54 97
≤12 months before baseline 24 123 71 218 13 1 13 27
>12 months before baseline 9 239 18 266 10 5 6 21
Total 45 362 121 528 449 6 73 528
Table 3 Outcome measures at baseline by timing of application
Timing of CDS application
Outcome measure Not by baseline ≤12 months before baseline >12 months before baseline p=0.03
HbA1c: mean (SD) 8.03 (1.99) 7.69 (1.82) 8.10 (1.87)
Seen at county or higher level hospital: % 53.6 81.6 65.9 0.00
Number of types of test: mean (SD) 1.28 (0.74) 1.62 (0.81) 1.42 (0.77) 0.00
Number of hospital visits: mean (SD) 2.94 (3.80) 5.48 (5.71) 4.93 (4.34) 0.00
SF-12 physical: mean (SD) 34.4 (8.9) 33.8 (8.1) 33.0 (7.9) 0.07
SF-12 mental: mean (SD) 39.6 (11.1) 37.9 (11.6) 37.7 (10.9) 0.03
EQ-5D health scale: mean (SD) 57.6 (14.4) 58.4 (14.3) 56.4 (14.3) 0.27
Cost of treatment ‘greatly burdensome’ % 38.2 48.6 57.1 0.00
N 524 245 287 –
(N = 1056)
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treatments. Few other differences were seen. Both male
and female cases had a somewhat higher mean body
mass index (BMI) than referents and male referents
were more likely to report that they drank alcohol. The
final columns of Table 4 show the odds ratios and 95 %
confidence intervals (CI) from a multilevel logistic
model allowing for the initial matching. It confirms that
the use of insulin is the baseline factor most clearly dif-
ferentiating those in the scheme, with small additional
differences, particularly for women, in years since diag-
nosis and BMI.
The difference between cases and referents on the
eight outcome measures, at baseline and follow-up are
shown for this study group in Table 5: probabilities of
the univariate comparison between cases and referents
are given, followed by odds ratios adjusted for use of
insulin, years since diagnosis and BMI as recorded at
baseline. No difference was seen in the extent to which
blood glucose control had been achieved, as reflected in
HbA1c, at baseline or follow-up. However, the markers
of quality of diabetes care were found to favour those in
the scheme: they were more likely to report having been
seen at a higher level hospital (county level or higher)
for their diabetes in the previous 12 months, both at
baseline and follow-up; they also reported at baseline
and follow-up that more of the 4 types of recommended
checks had been carried out and that they made more
hospital visits for their diabetes. In contrast the quality
of life measures were better for those not in the scheme,
particularly at baseline. The referents had higher ratings,
at both time points, on both the physical and mental
component scales of the SF-12 and had a better percep-
tion of their overall health, as reflected in their visual
analogue responses on the EQ-5D, although this differ-
ence was much less in evidence when the responses
were adjusted for use of insulin and time since diagnosis.
Finally those in the scheme felt more greatly burdened
by treatment costs at both contacts. None of the mea-
sures on which change could readily be measured
(HbA1c, tests, hospital visits, quality of life scales)
suggested a magnitude of change that differed between
cases and referents: both groups reported fewer tests
and better quality of life at follow-up and fewer in each
group reported feeling greatly burdened by the cost of
treatment.
This analysis gave information on how membership of
the scheme impacted on outcome measures, but not
(since all the cases were in the CDS at baseline) on
changes associated with newly receiving the card. The
subgroup most able to provide information on this com-
prised the 35 cases and 97 referents who said at baseline
they had not applied for the card, but that they had ap-
plied by the follow-up (Table 2). Of these 85 received
the card before the 12 month follow-up questionnaire
and 46 did not. It appears (Table 6) that those who did
not get the card showed a small deterioration in diabetes
control (HbA1c) between baseline and follow-up
whereas those who received the card had achieved better
control by the second assessment. No other difference
was seen between the groups except on the physical
component score of the SF-12, where those receiving
the card showed greater improvement.
Discussion
This study was designed to evaluate effects of the Anhui
Province chronic disease scheme on the health and well-
being of those in the province. We used diabetes as an
Table 4 Baseline characteristics of 258 matched pairs
(in scheme or not applied throughout)
Baseline characteristics Case Referent p= ORa 95 % CIa
Age
men: mean (SD) 58.1 (7.9) 54.4 (8.8) 0.87 0.98 0.93–1.03
women: mean (SD) 59.1 (7.2) 59.4 (6.6) 0.62 0.99 0.95–1.03
Years since diagnosisb
men: mean (SD) 6.2 (5.8) 4.8 (5.8) 0.16 1.02 0.95–1.09
women: mean (SD) 6.9 (5.2) 4.5 (3.9) 0.00 1.10 1.04–1.17
Body mass index
men: mean (SD) 26.0 (4.4) 24.8 (3.2) 0.06 1.00 0.99–1.01
women: mean (SD) 25.8 (4.0) 25.2 (3.6) 0.10 1.06 1.00–1.13
Use of insulin
Men: % 22.4 6.6 0.00 4.43 1.30–15.13
Women: % 26.4 2.2 0.00 15.16 4.45–51.67
Smoker now
Men: % 42.1 42.1 1.00 1.04 0.51–2.12
Women: % 0.5 2.2 0.72 0.60 0.05–4.30
Alcohol now
Men: % 26.3 40.8 0.08 0.61 0.28–1.31
Women: % 2.2 4.9 0.26 0.30 0.07–1.33
Working for money
Men: % 42.1 43.4 1.00 1.32 0.57–3.02
Women: % 7.7 12.6 0.25 0.53 0.23–1.23
Family income ‘lower than most’
Men: % 56.6 47.4 0.33 1.60 0.76–3.35
Women: % 55.5 61.0 0.34 0.64 0.39–1.04
Very low literacy
Men: % 22.4 18.4 0.69 1.35 0.55–3.27
Women: % 67.0 73.6 0.21 0.88 0.51–1.52
N
Men 76 76 – – –
women 182 182 – – –
aAdjusted for all other factors in table 3 in a multi-level logistic model
bAmong cases 3 men and 15 women could not recall the year of diagnosis
Among referents 2 men and 13 women could not recall the years of diagnosis
Jiang et al. BMC Public Health  (2016) 16:980 Page 6 of 10
exemplar condition as there is a biological marker
(HbA1c) that acts an indicator of the level of control
achieved by a patient with diabetes. As it was not feas-
ible to randomly allocate patients with diabetes to enroll
in the scheme, the comparison was primarily between
those who were enrolled in the scheme throughout and
those who did not apply, with a secondary, prospective,
comparison of change between baseline and follow-up of
those who applied since baseline. The results did not
suggest that those who had been enrolled in the scheme
throughout the study had better control of their diabetes
than those who never applied for the scheme. However
was some evidence that better control of diabetes was
present in those who had recently applied for the
scheme and, particularly those who had recently been
accepted, although it is not known whether this im-
provement would be sustained.
There are a number of ways in which interpretation of
these data are difficult. First, there is some uncertainty
about the date at which a patient was formally enrolled
in the scheme, with many registered by the NCMS office
as having been approved for a card reporting that they
had not yet received it. As such, the self-reported date of
application is used here as a proxy, but we are left in
some uncertainty about the extent to which investiga-
tions and advice associated with the (self-funded)
application process influenced the outcome measures of
diabetic control, diabetic care, quality of life and economic
Table 5 Outcome measures for 258 matched pairs (in scheme or not applied throughout)
Outcome measures Case Referent p= ORa 95 % CIa
HbA1c
Baseline: mean (SD) 8.06 (1.90) 7.97 (1.90) 0.60 0.96 0.89–1.06
Follow up: mean (SD) 8.07 (1.97) 8.10 (1.90) 0.83 0.92 0.83–1.02
Change: mean (SD) 0.00 (1.50) 0.13 (1.28) 0.30 0.93 0.81–1.07
Seen at county or higher level hospital
Baseline % 74.8 50.4 0.00 2.83 1.87–4.29
Follow up % 67.1 41.9 0.00 2.58 1.74–3.82
Number of test types
Baseline: mean (SD) 1.46 (0.73) 1.20 (0.67) 0.00 1.67 1.25–2.23
Follow up: mean (SD) 1.25 (0.66) 1.02 (0.64) 0.00 1.56 1.14–2.14
Change: mean (SD) −0.21 (0.89) −0.17 (0.83) 0.65 0.91 0.73–1.15
Number of hospital visits
Baseline: mean (SD) 5.47 (5.64) 2.50 (3.58) 0.00 1.24 1.15–1.33
Follow up: mean (SD) 5.82 (5.68) 2.58 (3.92) 0.00 1.15 1.09–1.21
Change: mean (SD) 0.35 (6.44) 0.09 (4.65) 0.59 1.00 0.97–1.04
SF–12 Physical
Baseline: mean (SD) 32.4 (7.7) 35.2 (9.1) 0.00 0.97 0.95–1.00
Follow up: mean (SD) 35.1 (7.2) 36.5 (7.5) 0.03 0.98 0.96–1.01
Change: mean (SD) 2.7 (8.9) 1.3 (9.6) 0.08 1.02 0.99–1. 04
SF–12 Mental
Baseline: mean (SD) 37.5 (10.5) 40.7 (11.3) 0.00 0.98 0.96–1.00
Follow up: mean (SD) 39.4 (10.8) 41.5 (10.9) 0.03 0.99 0.97–1.00
Change: mean (SD) 1.9 (12.5) 0.8 (12.5) 0.33 1.00 0.99–1.02
EQ–5D Health scale
Baseline: mean (SD) 56.2 (13.9) 59.5 (13.5) 0.01 0.99 0.98–1.04
Follow up: mean (SD) 62.2 (8.0) 64.5 (9.5) 0.00 0.98 0.96–1.00
Change: mean (SD) 2.7 (8.9) 1.3 (9.6) 0.08 1.00 0.99–1.02
Cost of treatment burdensome
Baseline: % 57.8 33.7 0.00 2.06 1.39–3.05
Follow up: % 33.7 16.3 0.00 1.95 1.22–3.10
N 258 258 – – –
aAdjusted for insulin, years since diagnosis and BMI at baseline in a multilevel logistic model allowing for clustering within pairs
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burden: it is difficult to disassociate the potential impact
of application from any health or other benefit arising
from use of the chronic disease card and the eligibility for
reimbursements once it is issued.
Second, as in all observational studies in which the
intervention (here membership of the CDS) is not
randomly assigned, there is a risk of selection bias:
although the province had a process in place to identify
all patients with diabetes and to offer enrolment in the
CDS to all who qualified, this was not fully achieved at
the time of this study. Most (>80 %) of decisions to
apply for the scheme were made at the suggestion of the
treating physician and it seems possible that those who
came forward as an early candidate for the scheme may
have had diabetes that was more difficult to control:
among the 256 pairs included in the primary analysis,
those in the scheme (particularly among the women)
had been diagnosed at an earlier date. They were some-
what more likely to report heart disease (12.8 % against
8.9 %) and renal disease (3.9 % against 0.8 %) at baseline
that those not in the scheme. They were also more likely
to be using insulin when recruited for the study (greater
than 20 % of those in the scheme reported insulin use at
baseline) but it is not known if this was a cause or result
of CDS membership. While such measured differences
between groups can be allowed for in the statistical
analysis (as, for example, in the odds ratios included in
Table 5) there may also be unmeasured differences that
Table 6 Outcome measures for those who applied after baseline: card received or not by follow up
Outcome measures Received Not received p= ORa 95 % CIa
HbA1c
Baseline: mean (SD) 8.38 (2.38) 7.92 (1.53) 0.24 1.09 0.90–1.31
Follow up: mean (SD) 7.95 (1.91) 8.12 (1.86) 0.73 0.96 0.79–1.17
Change: mean (SD) −0.43 (1.51) 0.20 (1.44) 0.02 0.74 0.56–0.99
Seen at county or higher level hospital
Baseline % 65.1 71.7 0.56 0.78 0.35–1.76
Follow up % 64.0 67.4 0.85 0.77 0.34–1.72
Number of test types
Baseline: mean (SD) 1.47 (0.89) 1.41 (0.78) 0.74 0.96 0.58–1.59
Follow up: mean (SD) 1.24 (0.61) 1.26 (0.49) 0.87 0.89 0.46–1.72
Change: mean (SD −0.22 (0.96) −0.15 (0.89) 0.69 0.98 0.63–1.53
Number of hospital visits
Baseline: mean (SD) 4.42 (4.67) 3.57 (4.08) 0.30 1.03 0.94–1.13
Follow up: mean (SD) 5.44 (5.71) 4.11 (5.08) 0.19 1.04 0.97–1.13
Change: mean (SD 1.02 (6.91) 0.54 (5.80 0.70 1.01 0.95–1.07
SF–12 Physical
Baseline: mean (SD) 31.51 (8.27) 34.53 (8.79) 0.05 0.96 0.92–1.00
Follow up: mean (SD) 34.95 (7.66) 33.92 (7.60) 0.46 1.02 0.97–1.07
Change: mean (SD) 3.44 (7.74) −0.61 (9.90) 0.01 1.06 1.01–1.10
SF–12 Mental
Baseline: mean (SD) 37.93 (10.13) 36.59 (11.68) 0.49 1.01 0.98–1.05
Follow up: mean (SD) 38.51 (10.24) 35.43 (10.47) 0.11 1.03 0.99–1.07
Change: mean (SD) 0.57 (10.99) −1.16 (11.42) 0.40 1.01 0.98–1.05
EQ–5D Health scale
Baseline: mean (SD) 54.93 (14.74) 53.13 (14.95) 0.51 1.01 0.99–1.04
Follow up: mean (SD) 59.40 (10.24) 62.30 (9.65) 0.12 0.97 0.93–1.01
Change: mean (SD) 4.47 (12.88) 9.17 (14.82) 0.06 0.97 0.94–1.00
Cost of treatment greatly burdensome
Baseline: % 54.7 45.7 0.36 1.37 0.64–2.92
Follow up: % 33.7 34.8 0.90 0.83 0.37–1.83
N 86 46 – – –
aAdjusted for insulin use at baseline in a multilevel logistic model allowing for clustering within county
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cannot be included as confounders (a problem also
referred to as endogeneity in this context [11]). Match-
ing patients in the scheme with referents who were not,
but were of the same age, sex and village may have
helped to reduce the effects of such unmeasured con-
founding, but is unlikely to have eliminated it entirely.
The high proportion of those in the CDS who felt that
the cost of diabetic treatment was greatly burdensome is
consistent with earlier studies showing that out of pocket
(OOP) expenses increased along with the greater use of
services associated with the introduction of the NCMS or
other types of health insurance. [5] Rural households
including members with chronic disease such as diabetes
have been shown to have much greater OOP outpatient
expenses than household with no chronic disease, and to
be at increased risk of catastrophic health expenditures,
even after reimbursements [12]. Although in the present
study partial reimbursement for outpatient care was avail-
able to those in the scheme, it is of interest that among
the 258 who had been in the scheme since baseline, only
176 (68 %) had received any reimbursements in the previ-
ous 12 months. The most common reason cited for not
being reimbursed was that the drugs they were prescribed
were not on the essential drugs list. In many, if not most,
cases the treating physician will have known that the
patient was in the CDS.
Finally, it is unclear why those studied reported feeling
less burdened and a higher quality of life at the follow-
up interview. This may have been from greater familiar-
ity with the research team, a more realistic assessment
of the role of the research (which may initially have been
seen as facilitating access to health benefits) or unrelated
changes in health care provision or other facilities for
rural inhabitants: without a referent group, these
improvements might have erroneously been attributed
to the CDS itself.
The question of whether health insurance improves
health, rather than simply access to health services, is
not readily answered but the finding of better (but still
not ideal) control of blood glucose amongst those
recently approved for the scheme does suggest that
reception of (and early compliance with) medical treat-
ment within the scheme may improve diabetic control,
at least in the short term: this finding, together with the
absence of effect of CDS membership for those longer in
the scheme, implies a need for continued active follow-
up of those recently accepted for the scheme, to
reinforce and maintain this early success. Systematic
review [13] and meta-analysis [14] suggest that changes
in the team or management plans for patients with type
2 diabetes can be effective in increasing control of blood
glucose and in decreasing long term risk of cardiovascu-
lar disease [15]. Longer follow-up of this cohort of
patients with diabetes would be needed to determine
whether CDS membership was associated with fewer
life-threatening complications of the disease.
Conclusion
On-going membership of the CDS was associated with
increased use of services but this did not appear to result
in better management of blood glucose or improved
quality of life. Those who had recently joined the
scheme had signs of improvement, suggesting a need for
active follow-up to maintain and reinforce early gains.
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